Raleukin
Raleukin (Anakinra/AMG-719), a recombinant, nonlysozymatized IL-1R antagonist, is the first-line agent for the treatment of hemophagocytic lymphohistiocytosis (HLH) and the first biologic agent to block pro-inflammatory effects.
|
Alternate Names |
Anakinra, AMG-719 |
|
Source |
Escherichia coli. |
|
M.Wt |
17257.6 |
|
Cas No. |
143090-92-0 |
|
Appearance |
Liquid |
|
Formula |
C759H1186N208O232S10 |
|
Cell experiment |
Proliferation, migration, and invasion: After an IL-1β (10 ng/mL)stimulation period of 3h, administration of anakinra (1 µg/mL, 48 h) strongly diminished expression of these cytokines in GBM and PBMC. Anakinra Dampened IL-1β-Induced Inflammatory Gene Expression in both cell populations1. ChIP assay: MEF cells were grown on 100 mm plates incubated with 10 μg/mL anakinra for 4 hours. Cells were then recovered in PBS 1× with MgCl2 1 mM, exposed to 1% formaldehyde at room temperature for 15 minutes to induce DNA crosslinking, washed, and then lysed with RIPA buffer containing 150 mM NaCl, 50 mM Tris pH 8.0, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% PIC, and PMSF2. |
|
Animal experiment |
C57BL6 WT mice were treated (i.p.) with 10 mg/kg anakinra reconstituted in sterile water daily for 6 consecutive days beginning the day of the infection2. |
|
Target |
IL-1 |
|
Pathway |
Immunology/Inflammation |
|
Stability & Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles |
|
Shipping Condition |
Dry ice |
|
Handling |
Centrifuge the vial prior to opening. |
|
Usage |
For Research Use Only! Not to be used in humans. |
| M.Wt | 17257.6 |
| Cas No. | 143090-92-0 |
| Formula | C759H1186N208O232S10 |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & DataSheet
- View current batch:
-
Purity ≥ 95 % by SDS-PAGE and HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet







